頁籤選單縮合
題 名 | 心血管疾病改善之經濟效益分析--旅行成本法之應用=Evaluating the Benefits of Ameliorating Cardiovascular Disease--An Application of the Travel Cost Method |
---|---|
作 者 | 李杰憲; | 書刊名 | 經濟研究. 臺北大學經濟學系 |
卷 期 | 46:1 2010.01[民99.01] |
頁 次 | 頁103-140 |
分類號 | 410.15 |
關鍵詞 | 心血管疾病; 風險因子; 旅行成本法; 截斷式負二項模型; Cardiovascular disease; Risk factors; Travel cost method; Truncated negative binomial model; |
語 文 | 中文(Chinese) |
中文摘要 | 本文引用旅行成本法 (travel cost method) 的概念,運用截斷式負二項模型 (truncated negative binomial model) 估計含有健康指標(血壓值、膽固醇值、血糖值、肥胖值)的醫療照護需求函數,並藉由觀察醫療照護需求的變化,探討改善心血管疾病的風險因子(高血壓,高膽固醇、糖尿病、肥胖)時,所能產生的經濟效益。實證結果顯示,以台閩地區而言,在考量患者的直接及間接醫療成本時,分別改善心血管疾病罹病者的血壓值、膽固醇值、血糖值、肥胖值狀況至平常人的水準,則健康指標改善總效益分別爲360億元、355億元、309億元、241億元。只考量直接醫療成本時,健康指標改善總效益分別爲317億元、313億元、272億元、212億元。若考量健康指標降到臨界值之健康指標改善效益,健康指標改善總效益分別爲125億元、242億元、145億元、97億元。 |
英文摘要 | This paper uses the Travel Cost Method (TCM) to evaluate the benefits from ameliorating cardiovascular disease. Data from the CVDFACTS project and NHI are used for the empirical analysis. Results using the truncated negative binomial regression model show that if we can ameliorate risk factors, such as hypertension, cholesterol, diabetes and obesity, among cardiovascular disease sufferers so that the risk levels are no higher than found in the general population the Benefits of Ameliorating Disease are cost of medical service can be reduced NT$ 36.0, 35.5, 30.9 and 24.1 billion respectively. It is believed that research the benefits from ameliorating cardiovascular disease researcher and policy executor for caring about should have reference value. |
本系統中英文摘要資訊取自各篇刊載內容。